Company Profile
Updated: 15-DEC-09ImClone Systems Inc.
Public Subsidiary, Headquarters Location
180 Varick St., New York, NY 10014-4606, United States
(877)925-6631, (212)645-1405, (212)645-2054 fax, http://www.imclone.com
Primary SIC: Biological Products Except Diagnostic, Primary NAICS: Biological Product (except Diagnostic) Manufacturing
Description: Manufacturing: Developer of biologic treatments designed to address the medical needs of patients with cancer.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
U.S. SEC eyes Nine Deals in Insider Trading Probe: Report
Reuters Hedgeworld; 12/10/2009; 776 words; ...Wyeth and Merck & Co. Inc.'s acquisition of Schering...including Abbott Laboratories Inc.'s acquisition of Advanced...Lilly & Co.'s buyout of ImClone Systems, the paper reported...retailer Best Buy Co. Inc.'s 2008 acquisition...
Cornerstone Therapeutics Appoints General Counsel.
Biotech Week; 11/25/2009; 705 words; ...General Counsel, Secretary, at ImClone Systems, Inc. where he led the legal and compliance...successfully structured and implemented ImClone's negotiated tender offer and...of CollaGenex Pharmaceuticals, Inc. where, from 2004-2008, he...
No Relief for Genzyme as APB Failure Dents Renal Franchise.
BIOWORLD Today; 11/19/2009; 1583 words; ...in pushing through acquisitions of MedImmune Inc. (by AstraZeneca plc) and ImClone Systems Inc. (by Eli Lilly & Co.), though attempts at putting Biogen Idec Inc. on the selling block have so far come to nothing...
Cancer Therapies - Global Market Opportunities.
M2 Presswire; 11/19/2009; 1505 words; ...developing and improving the healthcare system's screening systems, and abilities. Standard cancer treatments...Market Opportunities" by BizAcumen, Inc. Our reports are designed to be most...Initiates Phase III Trials of Cladribine - Imclone Awaits Approval for Erbitux from US Medicine...
Research and Markets: Cancer Therapies - Global Market Opportunities.
Business Wire; 11/19/2009; 1485 words; ...developing and improving the healthcare system's screening systems, and abilities. Standard cancer treatments...Market Opportunities" by BizAcumen, Inc. Our reports are designed to be most...Initiates Phase III Trials of Cladribine * Imclone Awaits Approval for Erbitux from US Medicine...
Recent News Articles
- Lilly shifting its attention to biotech research.(Health Care Heroes)(Eli Lilly and Co.)(ImClone Systems Inc.)
Indianapolis Business Journal - March 09, 2009 - Eli Lilly and Co.(ON THE RECORD)(acquisition of ImClone Systems Inc.)(Brief article)
Indianapolis Business Journal - February 02, 2009 - Eli Lilly and Co.(ON THE RECORD)(acquisition of ImClone Systems Inc.)(Brief article)
Indianapolis Business Journal - December 01, 2008 - Eli Lilly and Co.(ON THE RECORD)(Eli Lilly & Co has agreed to acquire ImClone Systems Inc )(Brief article)
Indianapolis Business Journal - November 10, 2008
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning